Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia
- PMID: 15938128
- DOI: 10.1007/s11011-005-4147-5
Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia
Abstract
In the present study we investigate the effect of homocysteine (Hcy) administration, the main metabolite accumulating in homocystinuria, on butyrylcholinesterase (BuChE) activity in serum of rats. For the acute treatment, 29-day-old Wistar rats received one subcutaneous injection of Hcy (0.6 micromol/g) or saline (control) and were killed 1 h later. For the chronic treatment, Hcy was administered subcutaneously to rats from the 6th to the 28th day of life. Control rats received saline. The rats were killed 12 h after the last injection. In another set of experiments, rats were pretreated for one week with vitamins E and C or saline and 12 h after the last injection received one single injection of Hcy or saline, being killed 1 h later. Serum was used to determine BuChE activity. Our results showed that acute and chronic administration of Hcy significantly decreased BuChE activity. Furthermore, vitamins E and C per se did not alter BuChE activity, but prevented the reduction of this enzyme activity caused by acute administration of Hcy. The data suggest that the inhibitory effect of Hcy on BuChE activity is probably mediated by free radicals, since vitamins E and C administration prevented such effect.
Similar articles
-
Folic acid pretreatment prevents the reduction of Na(+),K(+)-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia.Int J Dev Neurosci. 2006 Feb;24(1):3-8. doi: 10.1016/j.ijdevneu.2005.12.003. Epub 2006 Jan 25. Int J Dev Neurosci. 2006. PMID: 16442260
-
Homocysteine inhibits butyrylcholinesterase activity in rat serum.Metab Brain Dis. 2003 Sep;18(3):187-94. doi: 10.1023/a:1025551031767. Metab Brain Dis. 2003. PMID: 14567469
-
Acute and chronic hypermethioninemia alter Na+ K+-ATPase activity in rat hippocampus: prevention by antioxidants.Int J Dev Neurosci. 2011 Jun;29(4):483-8. doi: 10.1016/j.ijdevneu.2011.02.001. Epub 2011 Feb 24. Int J Dev Neurosci. 2011. PMID: 21354298
-
[Homocysteine and cardiovascular risk].Rev Med Liege. 1999 Jun;54(6):541-7. Rev Med Liege. 1999. PMID: 10446525 Review. French.
-
Homocysteine and Hyperhomocysteinaemia.Curr Med Chem. 2019;26(16):2948-2961. doi: 10.2174/0929867325666180313105949. Curr Med Chem. 2019. PMID: 29532755 Review.
Cited by
-
Neurological damage in MSUD: the role of oxidative stress.Cell Mol Neurobiol. 2014 Mar;34(2):157-65. doi: 10.1007/s10571-013-0002-0. Epub 2013 Nov 13. Cell Mol Neurobiol. 2014. PMID: 24220995 Free PMC article. Review.
-
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.Aging Dis. 2018 Feb 1;9(1):51-65. doi: 10.14336/AD.2017.0416. eCollection 2018 Feb. Aging Dis. 2018. PMID: 29392081 Free PMC article.
-
Homocysteine induces hypophosphorylation of intermediate filaments and reorganization of actin cytoskeleton in C6 glioma cells.Cell Mol Neurobiol. 2010 May;30(4):557-68. doi: 10.1007/s10571-009-9480-5. Epub 2009 Nov 24. Cell Mol Neurobiol. 2010. PMID: 19937110 Free PMC article.
-
Oxidative Stress in Homocystinuria Due to Cystathionine ß-Synthase Deficiency: Findings in Patients and in Animal Models.Cell Mol Neurobiol. 2017 Nov;37(8):1477-1485. doi: 10.1007/s10571-017-0478-0. Epub 2017 Mar 3. Cell Mol Neurobiol. 2017. PMID: 28258516 Free PMC article. Review.
-
Homocysteine thiolactone and human cholinesterases.Cell Mol Neurobiol. 2007 Feb;27(1):33-48. doi: 10.1007/s10571-006-9114-0. Epub 2006 Sep 6. Cell Mol Neurobiol. 2007. PMID: 16955366 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources